Soleno Therapeutics (SLNO) News Today $45.18 -0.02 (-0.04%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by BrokeragesShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have earned a consensus rating of "Buy" from the seven brokerages that are covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation onDecember 21 at 2:47 AM | marketbeat.com13,001 Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Bought by Teachers Retirement System of The State of KentuckyTeachers Retirement System of The State of Kentucky purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the third quarter, according to its most recent filing with the SEC. The fund purchased 13,001 shares of the company's stock, valued at approximately $656,000. SDecember 19 at 4:39 AM | marketbeat.comSoleno Therapeutics Secures $200 Million Debt Financing with Oxford FinanceDecember 19 at 4:17 AM | americanbankingnews.comState Street Corp Has $57.67 Million Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)State Street Corp boosted its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 14.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,142,169 shares of the company's stock aDecember 19 at 3:33 AM | marketbeat.comSoleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLCDecember 17, 2024 | globenewswire.comCritical Analysis: Positron (OTCMKTS:POSC) and Soleno Therapeutics (NASDAQ:SLNO)December 17, 2024 | americanbankingnews.comSoleno Therapeutics: PDUFA Extension May Be An Opportunity, But Not For MeDecember 14, 2024 | seekingalpha.comWellington Management Group LLP Purchases 290,135 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Wellington Management Group LLP lifted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 73.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 683,170 shares of the cDecember 13, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. increased its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 208.1% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 192,597 shares of the company's stocDecember 10, 2024 | marketbeat.comFmr LLC Raises Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Fmr LLC grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 6,048,754.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 665,374 shares of the company's stock after buying an additional 665,363 shares during the quarter. Fmr LLC owned 1.54December 9, 2024 | marketbeat.comPolar Asset Management Partners Inc. Sells 42,900 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Polar Asset Management Partners Inc. reduced its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 57.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 31,600 shares of the company's stock after seDecember 6, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for SLNO FY2024 Earnings?Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Equities research analysts at HC Wainwright raised their FY2024 earnings per share (EPS) estimates for Soleno Therapeutics in a research note issued to investors on Monday, December 2nd. HC Wainwright analyst R. Selvaraju now expects that thDecember 4, 2024 | marketbeat.comJanus Henderson Group PLC Has $206.02 Million Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Janus Henderson Group PLC raised its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 21.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,081,099 shares of the company's stock after purchasing an addDecember 4, 2024 | marketbeat.comHighVista Strategies LLC Buys New Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)HighVista Strategies LLC bought a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,085 shares of the company's stock,December 4, 2024 | marketbeat.comHolocene Advisors LP Increases Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Holocene Advisors LP raised its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 10.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 594,364 shares of the company's stock after purDecember 3, 2024 | marketbeat.comConfident Buy Rating on Soleno Therapeutics Amidst Imminent FDA Approval and Strong ValuationDecember 3, 2024 | markets.businessinsider.comStifel Nicolaus Remains a Buy on Soleno Therapeutics (SLNO)December 3, 2024 | markets.businessinsider.comMartingale Asset Management L P Takes $1.11 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Martingale Asset Management L P purchased a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 21,975 shares of the company's stock, valuDecember 2, 2024 | marketbeat.comShort Interest in Soleno Therapeutics, Inc. (NASDAQ:SLNO) Drops By 23.2%Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 4,740,000 shares, a drop of 23.2% from the October 31st total of 6,170,000 shares. Approximately 14.8% of the company's stock are short sold. Based on an average daily trading volume, of 654,000 shares, the days-to-cover ratio is presently 7.2 days.November 29, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by Vestal Point Capital LPVestal Point Capital LP cut its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 40.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 720,000 shares of the company's stock after selliNovember 29, 2024 | marketbeat.comWhat the Options Market Tells Us About Soleno TherapeuticsNovember 27, 2024 | benzinga.comSoleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare ConferenceNovember 27, 2024 | globenewswire.comSoleno Therapeutics slides after FDA review extension of its Prader-Willi syndrome treatmentNovember 26, 2024 | seekingalpha.comSoleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi SyndromeNovember 26, 2024 | globenewswire.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by BrokeragesShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have earned a consensus rating of "Buy" from the seven research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation and one has issued a stNovember 26, 2024 | marketbeat.comWestfield Capital Management Co. LP Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Westfield Capital Management Co. LP purchased a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 495,708 shares of the company's stocNovember 25, 2024 | marketbeat.comSoleno Therapeutics Reports Q3 Progress and FinancialsNovember 21, 2024 | markets.businessinsider.comSoleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024November 14, 2024 | globenewswire.comHere's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn SituationNovember 12, 2024 | finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Earns Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $70.00 price objective on shares of Soleno Therapeutics in a research note on Monday.November 11, 2024 | marketbeat.comPositive Outlook for Soleno Therapeutics: Buy Rating Based on Anticipated FDA Approval and Strong Cash PositionNovember 9, 2024 | markets.businessinsider.comCantor Fitzgerald Remains a Buy on Soleno Therapeutics (SLNO)November 8, 2024 | markets.businessinsider.comSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNovember 6, 2024 | finance.yahoo.comHarbor Capital Advisors Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Harbor Capital Advisors Inc. purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 36,048 shares of the company's stock, valued at approximately $1,82November 6, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Stock, Option ChainNovember 3, 2024 | benzinga.comEmerald Advisers LLC Increases Stock Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Emerald Advisers LLC raised its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 6.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 313,334 shares of the company's stock after buying an additioNovember 3, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Recommendation of "Buy" by AnalystsShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been assigned a consensus rating of "Buy" from the eight ratings firms that are presently covering the firm, Marketbeat reports. Seven research analysts have rated the stock with a buy rating and one has given a strong buy raNovember 1, 2024 | marketbeat.comSoleno Therapeutics price target raised to $73 from $65 at OppenheimerOctober 29, 2024 | markets.businessinsider.comSoleno Therapeutics (NASDAQ:SLNO) Hits New 12-Month High on Analyst UpgradeSoleno Therapeutics (NASDAQ:SLNO) Hits New 1-Year High on Analyst UpgradeOctober 28, 2024 | marketbeat.comSoleno Therapeutics to Participate in Upcoming November Investor ConferencesOctober 28, 2024 | tmcnet.comSoleno Therapeutics announces passing of former chairman Ernest MarioOctober 22, 2024 | markets.businessinsider.comSoleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.October 21, 2024 | markets.businessinsider.comSoleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCROctober 16, 2024 | msn.comSoleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome TreatmentOctober 16, 2024 | insidermonkey.com10 Biggest Stocks with Negative Beta to ConsiderOctober 14, 2024 | insidermonkey.comSoleno Therapeutics (NASDAQ:SLNO) Trading 6.4% Higher - Still a Buy?Soleno Therapeutics (NASDAQ:SLNO) Trading 6.4% Higher - Time to Buy?October 11, 2024 | marketbeat.comCarlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.October 10, 2024 | finance.yahoo.comSoleno Therapeutics Nears FDA Decision: Strong Buy Targeting PWS Hyperphagia TreatmentsOctober 10, 2024 | seekingalpha.comThe Manufacturers Life Insurance Company Raises Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)The Manufacturers Life Insurance Company lifted its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 120.7% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 49,408 shares of the company's stOctober 10, 2024 | marketbeat.comBelite Delights Investors, Soleno, ADMA, Harrow Deliver Triple-digit Gains, Keep An Eye On OculisOctober 9, 2024 | markets.businessinsider.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.870.60▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼74▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Glaukos News Bausch + Lomb News Inspire Medical Systems News PROCEPT BioRobotics News Axonics News NovoCure News Envista News Inari Medical News iRhythm Technologies News LivaNova News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLNO Stock Alerts